Header Logo

Connection

Anjan Pradhan to Molecular Targeted Therapy

This is a "connection" page, showing publications Anjan Pradhan has written about Molecular Targeted Therapy.
Connection Strength

0.133
  1. New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity. Adv Cancer Res. 2018; 137:77-114.
    View in: PubMed
    Score: 0.133
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.